Menu

Opinion: Debunking Junk

With more and more bad science infiltrating the media landscape, it’s time for researchers to speak up.

Feb 9, 2015
Edward Marks

Mehmet Oz was last year questioned by a Senate subcommitte regarding his statements on, among other things, a weight-loss supplement containing green coffee extractWIKIMEDIA, DAN BOLLINGER

At a time when half of Americans believe in at least one of six medical conspiracies—according to a May 2014 JAMA study—and celebrities with no medical background are giving medical advice to the public, there is a clear divide between scientific fact and general knowledge. Recently, one celebrity who does come from a medical background has come under fire: in connection with his claims regarding a weight-loss supplement, physician Mehmet Oz (“Dr. Oz”) was in June questioned by a Senate subcommittee; the research behind his statements on the compound was retracted in October.

Some of the blame can be put on us scientists. We like to think our research speaks for itself, that the peer-review process is efficient and relatively fair, and that the results we publish are therefore straightforward and easily understood. Our well-intentioned fervor behind finding the next new cancer drug or a cure for chronic illness can easily turn a statistically significant published result into a sensationalist media piece, however. If we carefully observe how our research is portrayed, we can make changes before the reporting gets out of hand.

Of course, the way we review the work of our peers can be problematic. As evidenced by the October 2013 Science investigation that found 157 journals willing to publish a “spoof” paper, the system has its flaws. To my mind, the most troubling implication of this investigation is that the improperly reviewed research can then be seen by the public. Worse yet, journalists can end up playing a game of telephone with the data, further skewing the message.

How can we ensure our data are accurately represented?

Some science advocates have emerged in the media, although our reliance on these figures is a double-edged sword. Neil deGrasse Tyson and Bill Nye, for example, are excellent science communicators. However, trained as a physicist and an engineer, respectively, they’re not likely the best voices for nanomedicine, microbiology, or most other life-science disciplines. Richard Dawkins has at times done a fine job explaining life science, but his polarizing personal views can drive away some who are simply seeking knowledge.

These famous science communicators should defer comment to experts in the field in question, broadening the public’s exposure of knowledgeable yet lesser-known scientists while at the same time decreasing the likelihood that the media will misunderstand the science.

As scientists, we too need to be communicators. We must speak for our research when necessary, call out media that misrepresent our results, and publicly reprimand those who are trying to make a quick buck by passing off shoddy or falsified research. Certain websites have done a wonderful job of publicly identifying these transgressions, but they are not enough. We have to condemn the offenders and extol the virtues of good science to the public and to one another. Only then will the discourse turn from distrust and blame to understanding, partnership, and respect.

Edward Marks is a PhD student at the University of Delaware. His research focus is on nanomedicines for cardiovascular disorders.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Preparing Cell Or Tissue Lysates For ELISA Kits

Preparing Cell Or Tissue Lysates For ELISA Kits

RayBiotech manufactures over 2,000 high fully validated, GMP-compliant ELISA kits. In this blog post we explain how to prepare cell or tissue lysates for ELISA Kits.

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on nucleic acid and protein stabilization and purification, as well as providing high quality services to the scientific community, today announced that it has become Propel-Certified through Illumina as a Next Generation Sequencing (NGS) service provider.

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.